Literature DB >> 11578485

Resection of bulky positive lymph nodes in patients with cervical carcinoma.

N.F. Hacker1, G.V. Wain, J.L. Nicklin.   

Abstract

From January 1987 to April 1992, 34 patients had resection of bulky positive lymph nodes, detected either at the time of radical hysterectomy (n = 23) or by computed tomographic (CT) scan of the pelvis and abdomen prior to radiation therapy for more advanced cervical cancer (n = 11). Following nodal resection, 33 patients received pelvic external beam radiation, 28 received pelvic and para-aortic radiation, and 23 received four cycles of cisplatin chemotherapy. The median number of resected positive nodes was 4, with a range of 1-44. All macroscopic nodal metastases could be resected in each patient and morbidity was acceptably low. Positive nodes were confined to the pelvis in 17 patients, involved the common iliac group in nine patients, and involved the para-aortic area in eight patients. With a mean follow-up of 36 months, 23 patients (67.6%) were alive, of whom 20 were free of disease. For patients having a radical hysterectomy, actuarial 5-year survival was 80% for patients with disease involving pelvic and common iliac lymph nodes, and 48% for those with positive para-aortic nodes. Survival for patients with completely resected bulky pelvic and common iliac nodes was comparable to that for patients with micrometastases. This study suggests that every effort should be made to identify patients with cervical cancer who have bulky positive lymph node metastases, and to remove these nodes surgically prior to radiation therapy.

Entities:  

Year:  1995        PMID: 11578485     DOI: 10.1046/j.1525-1438.1995.05040250.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  19 in total

Review 1.  Up-to-date management of lymph node metastasis and the role of tailored lymphadenectomy in cervical cancer.

Authors:  Noriaki Sakuragi
Journal:  Int J Clin Oncol       Date:  2007-06-27       Impact factor: 3.402

2.  Treatment outcomes and prognostic factors in uterine cervical cancer patients treated with postoperative extended field radiation therapy.

Authors:  Hak Jae Kim; Sung Whan Ha; Hong-Gyun Wu
Journal:  J Gynecol Oncol       Date:  2009-12-28       Impact factor: 4.401

3.  Utility of PET-CT to evaluate retroperitoneal lymph node metastasis in advanced cervical cancer: Results of ACRIN6671/GOG0233 trial.

Authors:  Mostafa Atri; Zheng Zhang; Farrokh Dehdashti; Susanna I Lee; Shamshad Ali; Helga Marques; Wui-Jin Koh; Kathleen Moore; Lisa Landrum; Jae Weon Kim; Paul DiSilvestro; Eric Eisenhauer; Frederick Schnell; Michael Gold
Journal:  Gynecol Oncol       Date:  2016-07-27       Impact factor: 5.482

4.  Debulking metastatic pelvic nodes before radiotherapy in cervical cancer patients: a long-term follow-up result.

Authors:  Tak-Hong Cheung; Keith Wing-Kit Lo; So-Fan Yim; Sau-Han Yau; May Mei-Yung Yu; Wing-Kay Yeung
Journal:  Int J Clin Oncol       Date:  2011-03-25       Impact factor: 3.402

5.  A critical overview of concurrent chemoradiotherapy in cervical cancer.

Authors:  Juan E Sardi; María A Boixadera; Juan J Sardi
Journal:  Curr Oncol Rep       Date:  2004-11       Impact factor: 5.075

6.  The abandoned radical hysterectomy for cervical cancer: clinical predictors and outcomes.

Authors:  Heidi J Gray; Erin Seifert; Victor G Sal Y Rosas; Katrina F Nicandri; Wui-Jin Koh; Barbara A Goff
Journal:  Obstet Gynecol Int       Date:  2010-04-28

7.  Experiences of pretreatment laparoscopic surgical staging in patients with locally advanced cervical cancer: results of a prospective study.

Authors:  Myong Cheol Lim; Jaeman Bae; Jeong-Yoel Park; Soyi Lim; Sokbom Kang; Sang-Soo Seo; Joo-Yong Kim; Ju-Won Rho; Sang-Yoon Park
Journal:  J Gynecol Oncol       Date:  2008-06-20       Impact factor: 4.401

8.  Whole slide quantification of stromal lymphatic vessel distribution and peritumoral lymphatic vessel density in early invasive cervical cancer: a method description.

Authors:  C Balsat; S Blacher; N Signolle; A Beliard; C Munaut; F Goffin; A Noel; J M Foidart; F Kridelka
Journal:  ISRN Obstet Gynecol       Date:  2011-08-25

9.  Laparoscopic transperitoneal infrarenal para-aortic lymphadenectomy in patients with FIGO stage IB1-II B cervical carcinoma.

Authors:  Dae G Hong; Nae Y Park; Gun O Chong; Young L Cho; Il S Park; Yoon S Lee; Dae Hyung Lee
Journal:  JSLS       Date:  2012 Apr-Jun       Impact factor: 2.172

10.  Intensity modulated radiotherapy in carcinoma cervix with metastatic para-aortic nodes: an institutional experience from a Regional Cancer Centre of Eastern India.

Authors:  Misra Biplab; Maji Tapas; Lahiri Debarshi; Roy Sanjoy; Chaudhuri Prabir; Ray K Dilip
Journal:  Rep Pract Oncol Radiother       Date:  2021-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.